Panagis Galiatsatos, Daniella D Maydan, Elle Macalpine, Beatrice Schleupner, Alexandra Hunter Aitchison, Andrew D Lerner, Benjamin Levy, Aditya Halthore, William Eward
Journal of cancer research and clinical oncology 2024 Mar 15Psoralen is a family of naturally occurring photoactive compounds found in plants that acquire potential cytotoxicity when activated by specific frequencies of electromagnetic waves. Psoralens penetrate the phospholipid cellular membranes and insert themselves between the pyrimidines of deoxyribonucleic acid (DNA). Psoralens are initially biologically inert and acquire photoreactivity when exposed to certain classes of electromagnetic radiation, such as ultraviolet light. Once activated, psoralens form mono- and di-adducts with DNA, leading to marked cell apoptosis. This apoptotic effect is more pronounced in tumor cells due to their high rate of cell division. Moreover, photoactivated psoralen can inhibit tyrosine kinase signaling and influence the immunogenic properties of cells. Thus, the cytotoxicity of photoactivated psoralen holds promising clinical applications from its immunogenic properties to potential anti-cancer treatments. This narrative review aims to provide an overview of the current understanding and research on psoralen and to explore its potential future pharmacotherapeutic benefits in specific diseases. © 2024. The Author(s).
Panagis Galiatsatos, Daniella D Maydan, Elle Macalpine, Beatrice Schleupner, Alexandra Hunter Aitchison, Andrew D Lerner, Benjamin Levy, Aditya Halthore, William Eward. Psoralen: a narrative review of current and future therapeutic uses. Journal of cancer research and clinical oncology. 2024 Mar 15;150(3):130
Mesh Tags
Substances
PMID: 38489072
View Full Text